EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pharmacokinetics of Pradofloxacin in Loggerhead Sea Turtles ( Caretta caretta ) After Single Intravenous and Subcutaneous Injections

Madeline M Yde iD, Mark G Papich iD, Gregory A Lewbart iD, Carly McCall iD, Craig A Harms iD

Journal of Veterinary Pharmacology and Therapeutics · 31.10.2026

DOI: 10.1111/jvp.70120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, online erschienen am 31.10.2026. Verfasst von Madeline M Yde und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pradofloxacin is approved orally for dogs and cats and parenterally for cattle and pigs in the U.S. The objective was to determine the pharmacokinetics of pradofloxacin in loggerhead turtles ( Caretta caretta ) and whether the plasma concentration is sufficient to treat susceptible bacteria. Pradofloxacin (200 mg/mL, diluted to 20 mg/mL in sterile saline) 10 mg/kg was administered SC and IV to 16 yearling loggerhead turtles with sparse sampling blood collection. Plasma concentrations were measured via high‐pressure liquid chromatography (HPLC). Pharmacokinetic analysis was performed with nonlinear mixed effects modeling. After SC administration, the peak plasma concentration ( C MAX ) was 9.31 μg/mL and the elimination half‐life was 1.2 h, with bioavailability greater than 100%. After IV administration, the elimination half‐life was 1.3 h, systemic clearance was 0.74 L/kg/h, and volume of distribution was 1.36 L/kg. Pradofloxacin was tolerated IV and SC and well absorbed SC. Despite favorable absorption and C MAX values, the clearance was faster, and half‐life shorter, than other fluoroquinolones in turtles and pradofloxacin in mammals. These concentrations may not be sufficient to reach pharmacokinetic‐pharmacodynamic targets (AUC/MIC) for treating gram‐positive and gram‐negative bacteria in the susceptibility category of < 0.25 μg/mL, according to clinical breakpoints approved by the Clinical & Laboratory Standards Institute.

Schlagwörter

Stichwörter der Autor:innen

antibioticfluoroquinolonepharmacokineticspradofloxacinsea turtles

Autor:innen und Institutionen

  • College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.
  • Center for Marine Sciences and Technology, North Carolina State University, Morehead City, North Carolina, USA.

ORCID-Profile: Madeline M Yde, Mark G Papich, Gregory A Lewbart, Carly McCall, Craig A Harms

Zitieren

APA

Yde, M. M., Papich, M. G., Lewbart, G. A., McCall, C., & Harms, C. A. (2026). Pharmacokinetics of Pradofloxacin in Loggerhead Sea Turtles ( Caretta caretta ) After Single Intravenous and Subcutaneous Injections. Journal of Veterinary Pharmacology and Therapeutics. https://doi.org/10.1111/jvp.70120

Vancouver

Yde MM, Papich MG, Lewbart GA, McCall C, Harms CA. Pharmacokinetics of Pradofloxacin in Loggerhead Sea Turtles ( Caretta caretta ) After Single Intravenous and Subcutaneous Injections. Journal of Veterinary Pharmacology and Therapeutics. 2026. doi:10.1111/jvp.70120

BibTeX
@article{Yde2026,
  author = {Yde, Madeline M and Papich, Mark G and Lewbart, Gregory A and McCall, Carly and Harms, Craig A},
  title = {Pharmacokinetics of Pradofloxacin in Loggerhead Sea Turtles ( Caretta caretta ) After Single Intravenous and Subcutaneous Injections},
  journal = {Journal of Veterinary Pharmacology and Therapeutics},
  year = {2026},
  doi = {10.1111/jvp.70120}
}
Kostenlos starten →